Drug development
The development of biotechnologically produced drugs has made it possible to treat diseases at their cause, to do this more efficiently and with fewer side effects, or even to cure diseases. This is the focus of five biotechnology companies on Campus Berlin-Buch.
The spectrum of their drug development includes highly specific cancer antibodies (Glycotope GmbH), novel treatments targeting the cause of heart failure (Berlin Cures GmbH) or atrial fibrillation (OMEICOS Therapeutics GmbH), extremely effective antibiotics (MerLion Pharmaceuticals) and RNAi-based therapeutics for systemic cancers that can selectively regulate disease-related genes (Silence Therapeutics). Here, T-Knife, a spin-off from the Charité and the Max Delbrück Center, is developing one of the first T cell receptor gene therapies in Germany.
News innovation
Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
Eckert & Ziegler (ISIN DE0005659700, SDAX) has successfully submitted a Type II Drug Master File (DMF) with the U.S. Food and Drug Administration for lutetium (177Lu) chloride solution (containing no-...
more ...Jury selects the best in youth science contest
“Mach Ideen groß” is the theme of this year’s nationwide “Jugend forscht” competition. At Campus Berlin-Buch the young scientists presented more than 20 projects. Seven of them made it to the regional...
more ...Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting
The Lausanne University Hospital (CHUV) has reported the initial dosing of a patient in a phase II clinical study investigating the sensitivity of PENTIXAFOR (Boclatixafotide) in a cardiovascular and ...
more ...Events Campus
28.03.2023, 13:30
CampusVital LOUNGE: Arzneimittel, Drogen, Gifte, Homöopathie – Was Sie darüber wissen sollten!
Die Verordnung von Arzneimitteln spielt in der Medizin eine zentral Rolle und trägt viel zu den Kosten unseres Gesundheitssystems bei. Ralf Schülein (Pharmakologe) erklärt, wie wirksame Substanzen in ...
more ...04.05.2023, 09:00
Bioinformatik im Labor 4.0
Eine eintägige Einführung für Technische Angestellte und Laborant*innen in die aktuelle Bioinformatik und in das Next Generation Sequencing (NGS) mit praktischen Übungen zum Umgang mit Biodatenbanken.
more ...
